GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » Equity-to-Asset

SNANF (Sona Nanotech) Equity-to-Asset : 0.53 (As of Jan. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Sona Nanotech's Total Stockholders Equity for the quarter that ended in Jan. 2025 was $1.17 Mil. Sona Nanotech's Total Assets for the quarter that ended in Jan. 2025 was $2.20 Mil.

The historical rank and industry rank for Sona Nanotech's Equity-to-Asset or its related term are showing as below:

SNANF' s Equity-to-Asset Range Over the Past 10 Years
Min: -4.74   Med: 0.06   Max: 0.71
Current: 0.53

During the past 13 years, the highest Equity to Asset Ratio of Sona Nanotech was 0.71. The lowest was -4.74. And the median was 0.06.

SNANF's Equity-to-Asset is ranked better than
55.75% of 226 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.63 vs SNANF: 0.53

Sona Nanotech Equity-to-Asset Historical Data

The historical data trend for Sona Nanotech's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Equity-to-Asset Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.74 -0.80 -0.97 0.42 0.67

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.48 0.22 -0.06 0.67 0.53

Competitive Comparison of Sona Nanotech's Equity-to-Asset

For the Diagnostics & Research subindustry, Sona Nanotech's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Equity-to-Asset Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Equity-to-Asset falls into.


;
;

Sona Nanotech Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Sona Nanotech's Equity to Asset Ratio for the fiscal year that ended in Oct. 2024 is calculated as

Equity to Asset (A: Oct. 2024 )=Total Stockholders Equity/Total Assets
=1.824/2.723
=

Sona Nanotech's Equity to Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

Equity to Asset (Q: Jan. 2025 )=Total Stockholders Equity/Total Assets
=1.171/2.197
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech  (OTCPK:SNANF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Sona Nanotech Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

From GuruFocus